Naomi Gronich

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 23

Top Topics

Atrial Fibrillation

St Segment Elevation Myocardial Infarction

Oral Anticoagulants

Top Venues

Clinical pharmacology and therapeutics

American journal of clinical dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Naomi Gronich, Bar Rosh, Nili Stein, Walid Saliba
Medications and Acute Hemolysis in G6PD-Deficient Patients - A Real-World Study. Clinical pharmacology and therapeutics (2024)
Naomi Gronich
Central Nervous System Medications: Pharmacokinetic and Pharmacodynamic Considerations for Older Adults. Drugs & aging 41 (6) (2024)
Naomi Gronich
Central Nervous System Medications: Pharmacokinetic and Pharmacodynamic Considerations for Older Adults. Drugs & aging 41 (6) (2024)
Naomi Gronich
Central Nervous System Medications: Pharmacokinetic and Pharmacodynamic Considerations for Older Adults. Drugs & aging (2024)
Naomi Gronich
Central Nervous System Medications: Pharmacokinetic and Pharmacodynamic Considerations for Older Adults. Drugs & aging 41 (6) (2024)
Naomi Gronich
Central Nervous System Medications: Pharmacokinetic and Pharmacodynamic Considerations for Older Adults. Drugs & aging 41 (6) (2024)
Naomi Gronich
Central Nervous System Medications: Pharmacokinetic and Pharmacodynamic Considerations for Older Adults. Drugs & aging 41 (6) (2024)
Haya Bishara, Anat Arbel, Ofra Barnett-Griness, Sivan Bloch, Shai Cohen, Ronza Najjar-Debbiny, Naomi Gronich, Eitan Auriel, Walid Saliba
Association Between Guillain-Barré Syndrome and COVID-19 Infection and Vaccination: A Population-Based Nested Case-Control Study. Neurology (2023)
Rachel Goldstein, Aviya R Jacobs, Lana Zighan, Naomi Gronich, Meir Bialer, Mordechai Muszkat
Interactions Between Direct Oral Anticoagulants (DOACs) and Antiseizure Medications: Potential Implications on DOAC Treatment. CNS drugs (2023)
Ofra Barnett-Griness, Gad Rennert, Flavio Lejbkowicz, Mila Pinchev, Walid Saliba, Naomi Gronich
Association Between ABCG2, ABCB1, ABCC2 Efflux Transporter Single-Nucleotide Variants and Irinotecan Adverse Effects in Patients With Colorectal Cancer: A Real-Life Study. Clinical pharmacology and therapeutics 113 (3) (2023)
Rachel Goldstein, Aviya R Jacobs, Lana Zighan, Naomi Gronich, Meir Bialer, Mordechai Muszkat
Interactions Between Direct Oral Anticoagulants (DOACs) and Antiseizure Medications: Potential Implications on DOAC Treatment. CNS drugs 37 (3) (2023)
Rachel Goldstein, Aviya R Jacobs, Lana Zighan, Naomi Gronich, Meir Bialer, Mordechai Muszkat
Interactions Between Direct Oral Anticoagulants (DOACs) and Antiseizure Medications: Potential Implications on DOAC Treatment. CNS drugs 37 (3) (2023)
Ofra Barnett-Griness, Gad Rennert, Flavio Lejbkowicz, Mila Pinchev, Walid Saliba, Naomi Gronich
Association Between ABCG2, ABCB1, ABCC2 Efflux Transporter Single-Nucleotide Variants and Irinotecan Adverse Effects in Patients With Colorectal Cancer: A Real-Life Study. Clinical pharmacology and therapeutics 113 (3) (2023)
Ofra Barnett-Griness, Gad Rennert, Flavio Lejbkowicz, Mila Pinchev, Walid Saliba, Naomi Gronich
Association Between ABCG2, ABCB1, ABCC2 Efflux Transporter Single-Nucleotide Variants and Irinotecan Adverse Effects in Patients With Colorectal Cancer: A Real-Life Study. Clinical pharmacology and therapeutics 113 (3) (2023)
Rachel Goldstein, Aviya R Jacobs, Lana Zighan, Naomi Gronich, Meir Bialer, Mordechai Muszkat
Interactions Between Direct Oral Anticoagulants (DOACs) and Antiseizure Medications: Potential Implications on DOAC Treatment. CNS drugs 37 (3) (2023)
Ofra Barnett-Griness, Gad Rennert, Flavio Lejbkowicz, Mila Pinchev, Walid Saliba, Naomi Gronich
Association Between ABCG2, ABCB1, ABCC2 Efflux Transporter Single-Nucleotide Variants and Irinotecan Adverse Effects in Patients With Colorectal Cancer: A Real-Life Study. Clinical pharmacology and therapeutics 113 (3) (2023)
Ofra Barnett-Griness, Gad Rennert, Flavio Lejbkowicz, Mila Pinchev, Walid Saliba, Naomi Gronich
Association Between ABCG2, ABCB1, ABCC2 Efflux Transporter Single-Nucleotide Variants and Irinotecan Adverse Effects in Patients With Colorectal Cancer: A Real-Life Study. Clinical pharmacology and therapeutics 113 (3) (2023)
Naomi Gronich, David Maman, Nili Stein, Walid Saliba
Culprit Medications and Risk Factors Associated with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Population-Based Nested Case-Control Study. American journal of clinical dermatology 23 (2) (2022)
Ofra Barnett-Griness, Gad Rennert, Flavio Lejbkowicz, Mila Pinchev, Walid Saliba, Naomi Gronich
Association between ABCG2, ABCB1, ABCC2 efflux transporters SNP's and irinotecan adverse effects in colorectal cancer patients: a real life study. Clinical pharmacology and therapeutics (2022)
Ofra Barnett-Griness, Gad Rennert, Flavio Lejbkowicz, Mila Pinchev, Walid Saliba, Naomi Gronich
Association Between ABCG2, ABCB1, ABCC2 Efflux Transporter Single-Nucleotide Variants and Irinotecan Adverse Effects in Patients With Colorectal Cancer: A Real-Life Study. Clinical pharmacology and therapeutics (2022)
Naomi Gronich, Nili Stein, Mordechai Muszkat
Association Between Use of Pharmacokinetic-Interacting Drugs and Effectiveness and Safety of Direct Acting Oral Anticoagulants: Nested Case-Control Study. Clinical pharmacology and therapeutics 110 (6) (2021)
Naomi Gronich, Idit Lavi, Flavio Lejbkowicz, Mila Pinchev, Yusri Zoabi, Eitan Auriel, Walid Saliba, Gad Rennert
Ischemic stroke and myocardial ischemia in clopidogrel users and the association with CYP2C19 loss-of-function homozygocity: a real-world study. The pharmacogenomics journal 21 (3) (2021)
Ofra Barnett-Griness, Nili Stein, Antonio Kotler, Walid Saliba, Naomi Gronich
Novel bleeding prediction model in atrial fibrillation patients on new oral anticoagulants. Heart (British Cardiac Society) (2021)